Grieco T, Faina V, Dies L, Milana M, Alei L, Silvestri E, Calvieri S
Department of Dermatology, Sapienza University of Rome, Italy.
Clin Ter. 2013 May-Jun;164(3):e207-9. doi: 10.7417/CT.2013.1570.
Alitretinoin is a unique retinoid authorised for the treatment of adults with severe chronic hand eczema (CHE) refractory to potent topical steroids. The most common adverse events (AEs) were typical class effects of oral retinoids including headache, flushing and skin disorders. To our knowledge, there are no cases of sensitization to alitretinoin reported in literature. We present a case of sensitization to alitretinoin.
